PRESS RELEASE published on 06/21/2024 at 09:30, 1 year 7 months ago Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee Audrey Duval Derveloy appointed Global Head of Corporate Affairs at Sanofi, joining Executive Committee. Responsible for stakeholder engagement and CSR strategy globally Executive Committee Sanofi Audrey Duval Derveloy Corporate Affairs Global Head
PRESS RELEASE published on 06/21/2024 at 09:15, 1 year 7 months ago Mutares expands Management Board Mutares SE & Co. KGaA expands Management Board with appointment of Johannes Laumann as CIO and Dr Lennart Schley as COO to drive growth and internationalization efforts Mutares SE & Co. KGaA Growth Management Board Johannes Laumann Dr Lennart Schley
PRESS RELEASE published on 06/21/2024 at 09:00, 1 year 7 months ago HDBank: Credit growth is bright spot for banking Vietnamese banks, including HDBank, face challenges in credit growth but show profitability. State Bank aims for 5-6% growth rate by Q2 Profitability HDBank Credit Growth Vietnamese Banks State Bank
PRESS RELEASE published on 06/21/2024 at 09:00, 1 year 7 months ago Swiss Merchant Group AG has arranged the bluex AG corporate bond issue with the ISN: CH 1360966472 Swiss Merchant Group AG arranges blue8X AG corporate bond issue ISIN: CH1360966472 to finance acquisitions of solar companies in Switzerland Swiss Merchant Group AG Blue8X AG Corporate Bond Issue CH1360966472 Solar Companies
REGULATED PRESS RELEASE published on 06/21/2024 at 08:35, 1 year 7 months ago bioMérieux receives US FDA 510(k) clearance for its AST System VITEK® REVEAL™ bioMérieux's VITEK® REVEAL™ AST System receives FDA 510(k) clearance, enabling rapid antimicrobial susceptibility testing from positive blood cultures BioMérieux FDA 510(k) Clearance Antimicrobial Susceptibility Testing VITEK® REVEAL™ AST System
REGULATED PRESS RELEASE published on 06/21/2024 at 08:35, 1 year 7 months ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour son système d’antibiogramme VITEK® REVEAL™ bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour son système d’antibiogramme VITEK® REVEAL™. Une avancée majeure pour le diagnostic des sepsis et la lutte contre l'antibiorésistance FDA BioMérieux Diagnostic In Vitro Autorisation 510(k) Antibiogramme VITEK REVEAL
PRESS RELEASE published on 06/21/2024 at 08:30, 1 year 7 months ago Befesa has acquired the full ownership of French Recytech joint venture, moving forward with its strategic global growth plan in Europe Befesa acquires full ownership of French Recytech joint venture from Recylex S.A., enhancing global growth strategy in Europe Acquisition Strategic Growth Befesa Recytech Steel Dust Recycling
PRESS RELEASE published on 06/21/2024 at 08:30, 1 year 7 months ago Nomination de Monsieur Gilles-Emmanuel TRUTAT en qualité de Président Nomination de Monsieur Gilles-Emmanuel TRUTAT en qualité de Président chez WELL, société d'investissement. M. Trutat apportera son expertise pour le développement de l'entreprise Investissement President Gilles-Emmanuel Trutat WELL ODIOT
PRESS RELEASE published on 06/21/2024 at 08:30, 1 year 7 months ago Appointment of Mr. Gilles-Emmanuel TRUTAT as President WELL appoints Mr. Gilles-Emmanuel Trutat as Chairman, focusing on ODIOT luxury brand. Trutat brings extensive experience to enhance WELL's success Investment Company Gilles-Emmanuel Trutat WELL ODIOT Luxury Brand
PRESS RELEASE published on 06/21/2024 at 08:01, 1 year 7 months ago Tocvan Reports on Progress of the Pilar Gold - Silver Project Tocvan Ventures Corp. provides a progress update on the 2024 Reverse Circulation (RC) drill program at its Pilar Gold-Silver project in Sonora, Mexico. Significant drilling progress and new exploration activities reported Tocvan Ventures Corp. Drill Program Exploration Activities Pilar Gold-silver Project Sonora, Mexico
Published on 01/26/2026 at 19:55, 4 hours 23 minutes ago Alta Copper Shareholders and Optionholders Approve Proposed Acquisition by Fortescue
Published on 01/26/2026 at 19:00, 5 hours 18 minutes ago Critical Elements Lithium Corp Announces Investor Relations Partnership With Adelaide Capital and Oak Hill Capital
Published on 01/26/2026 at 19:00, 5 hours 18 minutes ago Critical Elements Lithium Corp Annonces Un Partenariat en Matière De Relations Avec Les Investisseurs Avec Adelaide Capital and Oak Hill Capital
Published on 01/26/2026 at 18:55, 5 hours 23 minutes ago Kingsmen Resources Announces Upsize of Bought Deal Private Placement to Gross Proceeds of C$11 Million
Published on 01/26/2026 at 15:42, 8 hours 36 minutes ago Greenlane to Deploy up to 30 Million Units of BERA Into Validator Infrastructure to Participate in Protocol-Level Yield Mechanisms, Bringing Total Validator Deployment to up to 50 Million Units
Published on 01/26/2026 at 19:32, 4 hours 46 minutes ago GEA publishes preliminary figures and exceeds expectations for key financial indicators for 2025, confirms accelerated sales growth in 2026
Published on 01/26/2026 at 19:00, 5 hours 18 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 19 JANVIER 2026 au 23 JANVIER 2026
Published on 01/26/2026 at 18:56, 5 hours 22 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/26/2026 at 18:41, 5 hours 37 minutes ago EQS-Adhoc: The Platform Group: Intended Acquisition of the AEP Pharma Group with EUR 1 Billion in Profitable Revenue and a New Independent Business Segment
Published on 01/26/2026 at 18:30, 5 hours 48 minutes ago DocMorris repurchases convertible bonds maturing in 2026 with a nominal value of around CHF 14.4 million
Published on 01/26/2026 at 18:00, 6 hours 18 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 20 et le 21 janvier 2026
Published on 01/26/2026 at 18:00, 6 hours 18 minutes ago Reporting on share buyback transactions carried out between January 20 and January 21, 2026
Published on 01/26/2026 at 17:45, 6 hours 33 minutes ago Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments
Published on 01/26/2026 at 17:45, 6 hours 33 minutes ago Gimv verhoogt focus op strategische doelstellingen en discontinueert activiteiten voor nieuwe Life Sciences investeringen
Published on 01/26/2026 at 17:45, 6 hours 33 minutes ago Gimv increases focus on strategic objectives and discontinues activities for new Life Sciences investments